Fontes de obtenção de medicamentos para hipertensão e diabetes no Brasil: resultados de inquérito telefônico nas capitais brasileiras e no Distrito Federal, 2011

Costa, Karen Sarmento; Francisco, Priscila Maria Stolses Bergamo; Malta, Déborah Carvalho; Barros, Marilisa Berti de Azevedo

doi:10.1590/0102-311x00090014

Cited by 23 publications

(40 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Many efforts have contributed to the decline in DALY rates from 1990 to 2016 and should be considered a priority, including improved access to primary care and care for related risk factors, such as hypertension; access to free or subsidised drugs for hypertension, diabetes, and asthma; and access to and prioritisation of care for acute cardiovascular events 4, 54, 55, 56. Tackling ischaemic heart disease poses a double challenge to health systems: prevention must take place alongside improvements in health-care delivery, particularly in public hospitals 54 .…”

Section: Discussionmentioning

confidence: 99%

Burden of disease in Brazil, 1990–2016: a systematic subnational analysis for the Global Burden of Disease Study 2016

Marinho¹,

Passos²,

Malta³

et al. 2018

The Lancet

273

191

View full text Add to dashboard Cite

SummaryBackgroundPolitical, economic, and epidemiological changes in Brazil have affected health and the health system. We used the Global Burden of Disease Study 2016 (GBD 2016) results to understand changing health patterns and inform policy responses.MethodsWe analysed GBD 2016 estimates for life expectancy at birth (LE), healthy life expectancy (HALE), all-cause and cause-specific mortality, years of life lost (YLLs), years lived with disability (YLDs), disability-adjusted life-years (DALYs), and risk factors for Brazil, its 26 states, and the Federal District from 1990 to 2016, and compared these with national estimates for ten comparator countries.FindingsNationally, LE increased from 68·4 years (95% uncertainty interval [UI] 68·0–68·9) in 1990 to 75·2 years (74·7–75·7) in 2016, and HALE increased from 59·8 years (57·1–62·1) to 65·5 years (62·5–68·0). All-cause age-standardised mortality rates decreased by 34·0% (33·4–34·5), while all-cause age-standardised DALY rates decreased by 30·2% (27·7–32·8); the magnitude of declines varied among states. In 2016, ischaemic heart disease was the leading cause of age-standardised YLLs, followed by interpersonal violence. Low back and neck pain, sense organ diseases, and skin diseases were the main causes of YLDs in 1990 and 2016. Leading risk factors contributing to DALYs in 2016 were alcohol and drug use, high blood pressure, and high body-mass index.InterpretationHealth improved from 1990 to 2016, but improvements and disease burden varied between states. An epidemiological transition towards non-communicable diseases and related risks occurred nationally, but later in some states, while interpersonal violence grew as a health concern. Policy makers can use these results to address health disparities.FundingBill & Melinda Gates Foundation and the Brazilian Ministry of Health.

show abstract

Section: Discussionmentioning

confidence: 99%

Burden of disease in Brazil, 1990–2016: a systematic subnational analysis for the Global Burden of Disease Study 2016

Marinho¹,

Passos²,

Malta³

et al. 2018

The Lancet

273

191

View full text Add to dashboard Cite

show abstract

“…Therefore, using the criterion of having high blood pressure or taking medication led the prevalence rate to reach more than one third of the adult population, reaching more than 70% of the population aged more than 70 years. The wide access to medication for hypertension and diabetes in the Unified Health System (SUS) stands out, as well as the gratuity programs, such as "Aqui tem Farmácia Popular" 24,32 .…”

Section: Regionsmentioning

confidence: 99%

Prevalência da hipertensão arterial segundo diferentes critérios diagnósticos, Pesquisa Nacional de Saúde

Malta

Gonçalves

Machado

et al. 2018

Rev. bras. epidemiol.

View full text Add to dashboard Cite

RESUMO: Objetivo: Determinar a prevalência populacional de hipertensão arterial em adultos, segundo diferentes critérios diagnósticos. Métodos: Trata-se de um estudo transversal, que analisa informações da Pesquisa Nacional de Saúde de 2013, que consistiu em entrevistas, medidas físicas e laboratoriais da população brasileira (n = 60.202). A prevalência de hipertensão arterial foi definida segundo três critérios diagnósticos: hipertensão autorreferida; medida por instrumento (pressão arterial ≥ 140/90 mmHg); medida e/ou em uso de medicamentos anti-hipertensivos. Foram estimadas as prevalências de hipertensão arterial segundo os três critérios diagnósticos e seus respectivos intervalos de confiança de 95% (IC95%). Resultados: As prevalências de hipertensão arterial encontradas foram: 21,4% (IC95% 20,8 - 22,0) utilizando-se o critério autorreferido, 22,8% (IC95% 22,1 - 23,4) para hipertensão arterial medida e 32,3% (IC95% 31,7 - 33,0) para hipertensão arterial medida e/ou relato de uso de medicação. As mulheres apresentaram prevalências de hipertensão mais elevadas no critério autorreferido (24,2%; IC95% 23,4 - 24,9). Entre os homens, a prevalência foi maior no critério hipertensão arterial medida (25,8%; IC95% 24,8 - 26,7). Utilizando os três critérios, a hipertensão arterial aumentou com a idade, foi mais frequente na região urbana e maior nas regiões sudeste e sul, em relação à média do país e às demais regiões. Conclusão: Estes resultados são importantes para apoiar políticas que visem atingir a meta da Organização Mundial de Saúde de redução da hipertensão em 25% na próxima década.

show abstract

“…Similarmente, Boing et al 11 constataram que o Sul e o Sudeste apresentaram, respectivamente, as maiores prevalências de acesso aos medicamentos no setor público entre pessoas que tiveram prescrição no próprio sistema público. Costa et al 19 também observaram que, entre diabéticos e hipertensos, os maiores percentuais de obtenção de medicamentos em unidades de saúde foram nas regiões Sul e Sudeste do país, respectivamente.…”

Section: Tabelaunclassified

Fontes de obtenção de medicamentos por pacientes diagnosticados com doenças crônicas, usuários do Sistema Único de Saúde

et al. 2018

Self Cite

View full text Add to dashboard Cite

The article aimed to identify the sources of medicines for users of the Brazilian Unified National Health System (SUS) that reported chronic non-communicable diseases, characterizing the group according to demographic, socioeconomic, and health variables in the different regions of Brazil. Data were analyzed from the National Survey on Access, Use, and Promotion of Rational Use of Medicines in Brazil (PNAUM), a cross-sectional population-based study. The dependent variable was "source of medicines", and the associations were analyzed with demographic, socioeconomic, and health status variables. Users that obtained care and medicines solely in the SUS were designated here as SUS-exclusive. Some 39% of persons obtained their medicines from SUS pharmacies and 28.5% from other sources. The study found 42.9%, 41.8%, 40.2%, and 31% of exclusive SUS users in the Southeast, South, North, and Northeast regions of Brazil, respectively. SUS users have the SUS as their primary source of medicines, but there is also a relevant share from other sources, suggesting problems with access in the SUS. In the South and Southeast regions, the population relies less on private pharmacies than in the Northeast and North.

show abstract

Fontes de obtenção de medicamentos para hipertensão e diabetes no Brasil: resultados de inquérito telefônico nas capitais brasileiras e no Distrito Federal, 2011

Cited by 23 publications

References 10 publications

Burden of disease in Brazil, 1990–2016: a systematic subnational analysis for the Global Burden of Disease Study 2016

Burden of disease in Brazil, 1990–2016: a systematic subnational analysis for the Global Burden of Disease Study 2016

Prevalência da hipertensão arterial segundo diferentes critérios diagnósticos, Pesquisa Nacional de Saúde

Fontes de obtenção de medicamentos por pacientes diagnosticados com doenças crônicas, usuários do Sistema Único de Saúde

Contact Info

Product

Resources

About